KalVista Pharmaceuticals (KALV) Tops Q3 EPS by 23c

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q3 EPS of ($0.75), $0.23 better than the analyst estimate of ($0.98).

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Workday shares slide 5% as revenue outlook offers little upside surprise
• The Gap, Inc. (GAP) Tops Q2 EPS by 3c